echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > Expert Report Replay 2022 Ibrain Journals Annual Conference & 2nd International Neuroscience Summit Forum

    Expert Report Replay 2022 Ibrain Journals Annual Conference & 2nd International Neuroscience Summit Forum

    • Last Update: 2022-09-21
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com



    From August 16 to 17, 2022, the 2022 Ibrain Journals Academic Annual Conference and the Second International Neuroscience Summit Forum were successfully held in the form of offline and online, and the whole conference was broadcast live



    After the opening ceremony, Ibrain Editor-in-Chief Professor Wang Tinghua, Director of the Neurological Disease Research Office of West China Hospital of Sichuan University, Professor Xin-Fu Zhou of the University of South Australia, Associate Editor of Ibrain, Professor Tian Xiaohe of West China Hospital of Sichuan University, Professor Giuseppe Battaglia, Department of Molecular Biomimics, University College London, Professor Loris Rizzello, National Institute of Molecular Genetics, Italy, Professor Li Tianqing, Minister of Education of the Institute of Primate Translational Medicine of Kunming University of Science and Technology, Professor Li Yunqing, a scholar of the Ministry of Education, and other experts made wonderful academic reports



    Wonderful not to be missed, welcome to scan the code to watch the August 16 expert report replay!


    Report content



    About Ibrain



    Ibrain is a global leader in research and education, an English-language open access journal



    Journal publication scope and topics:

    Ibrain is interested in topics related to brain, spinal cord, and neurological diseases, including, but not limited to, clinical medicine, molecular diagnostics, epigenetics/genetics, cell biology, drug discovery, evolutionary medicine, nanotechnology, and artificial intelligence



    Topics published in the journal include, but are not limited to:

    Types of journal articles published:

    • Original article

    • Reviews

    • Comments

    • Case reports

    • Letter

    • Methods


    Journals in 2022-2024 are exempt from publication fees (APCs
    ).

    Currently, Ibrain is included in the international search database DOAJ, and it takes only two months
    from the filing of the application to the time it is included in the DOAJ.

    We sincerely welcome researchers, doctors and graduate students in the field of neuroscience to actively submit articles to the journal!

    Submission Links:

    https://mc.
    manuscriptcentral.
    com/ibra

    Special Issue Call for Papers

    Ibrain will publish a special issue publishing the latest basic and clinical research
    on CNS injury injection materials.

    It will focus on the molecular mechanisms of the use of injectable materials to repair brain injuries, basic and clinical studies of effective injection materials, and related topics
    .

    We cordially invite researchers to provide original research papers or review articles
    for this special issue.

    We can waive your publication fee and provide authors with fast access to
    publication.

    https://onlinelibrary.
    wiley.
    com/page/journal/27692795/themed-collections/injectable_materials

    Related Reading

    • Ibrain | Ultrasound-guided peripheral trunk block technology: a new approach that is gradually taking the stage of clinical anesthesia
    • Ibrain Special Issue invites you to submit!
    • Good news | Congratulations to Ibrain for being included in the DOAJ database!
    • Ibrain | Study on the role of sevoflurane in cognitive function in elderly rats based on cortical microglia activation
    • The opening ceremony of the inaugural medical journal Ibrain, jointly organized by Wiley Publishing Group, Zunyi Medical University and Affiliated Hospitals, was successfully held

    Content | Wiley

    Wiley is a global leader in research and education, inspiring human potential
    by facilitating discovery, empowering education, and shaping talent.

    For more than 200 years, Wiley has driven the development of a
    global knowledge ecosystem.

    Today, our high-impact content, platforms, and services help researchers, learners, institutions, and businesses achieve their goals
    in a rapidly changing world.

    Wiley, headquartered in Hoboken, New Jersey, USA, is listed on the New York Stock Exchange under the symbols WLY and WLYB
    .

    Like, watch, share, have a one-click triple!

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.